Circulating Anticoagulant against Factor XII and Thrombocytopenic Purpura

• References

• 1 Aberg H, Nilsson IM. Recurrent thrombosis in a young woman with a circulating anticoagulant directed against Factors XI and XII. Acta Med Scand 1972; 192: 419-425
• 2 Gandolfo GM, Afeltra A, Amoroso A, Biancolella F, Ferri GM. Circulating anticoagulant against Factor XII and platelet antibodies in Systemic Lupus Erythematosus. Acta Hematol 1977; 57: 135-142
• 3 Bateman d, Gokal R, Prescott R, Hamilton PS, Kerr DN S. Minimal change glomerulonephritis associated with circulating anticoagulant to Factor XII. Br Med J 1980; 2: 358
• 4 Duran JR, Vila M, Rodriguez BuenoS, Triginer J. Circulating anticoagulant against Factor XII in smoldering leukemia. Acta Haematol 1982; 67: 128-131
• 5 Valentin IR, Rimon A, Lahav M. Inhibition of blood coagulation Factor XI und XII by monoclonal IgM (abstract). Israel J Med Sci 1975; 11: 1392
• 6 Cronberg S, Nilsson IM. Circulating anticoagulant against Factors XI and XII together with massive spontaneous platelet aggregation. Scand J Hematol 1973; 10: 309-314
• 7 Rolović Z, Elezović I, Obranović B, Rizza C. Life threatening bleeding due to an acquired inhibitor to Factor XII-XI successfully treated with „activated“ prothrombin complex concentrate (FEIBA). Br J Haematol 1982; 51: 659
• 8 Odgston D, Bennet B. (eds) Haemostasis. 1. A Wiley Interscience Publication; London: 1977. p 487
• 9 Caen J, Larrieu MJ, Samama M. La Hemostasia. 1a . Toray Masson SA. Barcelona: 1977. p 170